Skip to content

Stock atrx

Stock atrx

Find real-time ATRX - Adhera Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ATRX News and Headlines - Adhera Therapeutics GuruFocus Articles Total 0 1; Headlines Total 3 1; 2019-09-27 $ 0.09 (-10%) 7:00pm . Adhera Therapeutics Announces Termination of Tender Offer for Preferred Stock - GuruFocus.com. 2019-07-03 $ 0.15 (%) 7:02pm. Adhera Therapeutics Announces Termination of Tender Offer for Warrants - GuruFocus.com. 2019-04-04 $ 0.37 (%) 11:01am. Adhera … 20/07/2020 Get today's Adhera Therapeutics Inc stock price and latest ATRX news as well as Adhera Therapeutics real-time stock quotes, technical analysis, full financials and more. 01/12/2019

Market Data is delayed by 15 minutes and is for informational and/or educational purposes only. In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that determination.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Back. Adhera Therapeutics, Inc. (ATRX) Add to watchlis ADHERA THERAPEUTIC Stock Price, Chart, Latest News, Technical Indicator and other information. All Stocks StockAP › Stocks › ATRX ATRX (OTC) 0.0360 Adhera Therapeutics, Inc. (ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, today announced that it has terminated its previously announced offer to exchange all of the warrants to purchase shares of the common stock of the Company that the Company issued in connection with its private placements of Series E Thinking about buying or selling stock in ATRX? See the latest Adhera Therapeutics Inc (ATRX) stock analysis, price, forecast, news and more.

Adhera Therapeutics Inc (ATRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.

Adhera Therapeutics, Inc. (ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, today announced that it has terminated its previously announced offer to exchange all of the outstanding shares of the Series E Convertible Preferred Stock and Series F Convertible Preferred Stock of the Company. As per the terms of the Find real-time ATRX - Adhera Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, ATRX. Adhera Therapeutics Inc. Common Stock 

Spontaneous mutations in the human ATRX gene induce a complex neurological syndrome that includes mild α-thalassemia, mental retardation with facial  Amorim, J.P.; Santos, G.; Vinagre, J.; Soares, P. The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype. Knockout Tested Mouse monoclonal ATRX antibody [CL0537]. Validated in WB, IHC, ICC/IF and tested in Human. Cited in 1 publication(s). Immunogen 

Stock Ideas. Long Ideas; IPO Analysis; Quick Picks and Lists; Fund Letters; Closed End Funds; Stock Ideas by Sector ; Stock Ideas Editors Picks; Short Ideas; Dividends. Dividend Ideas; Dividend

View today's stock price, news and analysis for Adhera Therapeutics Inc. (ATRX). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

Apex Business WordPress Theme | Designed by Crafthemes